The NIH-funded Initiative for Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND-TB) led by Rutgers University and FIND are inviting developers of TB diagnostics to submit proposals for evaluation of early-stage TB diagnostics and novel testing strategies.
The FEND-TB initiative provides access to adaptable and open trial protocols, with the aim to conduct clinical studies, laboratory evaluations of prototype assays, and economic analysis, along with transmission modelling.
Please see this PDF for more information.
